Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

BACKGROUND: The primary objective was to determine maximum tolerated radiation dose in patients with metastatic renal cell carcinoma on pazopanib treatment. METHODS: Treatment-naïve patients received pazopanib according to standard of care. Stereotactic body radiotherapy (SBRT) was delivered concurr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Radiat Oncol
Hlavní autoři: De Wolf, Katrien, Rottey, Sylvie, Vermaelen, Karim, Decaestecker, Karel, Sundahl, Nora, De Lobel, Lizzy, Goetghebeur, Els, De Meerleer, Gert, Lumen, Nicolaas, Fonteyne, Valérie, De Maeseneer, Daan, Ost, Piet
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5610443/
https://ncbi.nlm.nih.gov/pubmed/28938918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0893-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky